GB0918912D0 - Improved medicament formulation - Google Patents

Improved medicament formulation

Info

Publication number
GB0918912D0
GB0918912D0 GBGB0918912.7A GB0918912A GB0918912D0 GB 0918912 D0 GB0918912 D0 GB 0918912D0 GB 0918912 A GB0918912 A GB 0918912A GB 0918912 D0 GB0918912 D0 GB 0918912D0
Authority
GB
United Kingdom
Prior art keywords
medicament formulation
improved medicament
improved
formulation
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0918912.7A
Other versions
GB2464825B (en
GB2464825A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bomac Research Ltd
Original Assignee
Bomac Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bomac Research Ltd filed Critical Bomac Research Ltd
Publication of GB0918912D0 publication Critical patent/GB0918912D0/en
Publication of GB2464825A publication Critical patent/GB2464825A/en
Application granted granted Critical
Publication of GB2464825B publication Critical patent/GB2464825B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB0918912A 2008-10-31 2009-10-29 Parenteral formulation for the combined delivery of iodised unsaturated vegetable oil and barium selenate Active GB2464825B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ572491A NZ572491A (en) 2008-10-31 2008-10-31 Composition for prevention and treatment of iodine and selenium deficiency

Publications (3)

Publication Number Publication Date
GB0918912D0 true GB0918912D0 (en) 2009-12-16
GB2464825A GB2464825A (en) 2010-05-05
GB2464825B GB2464825B (en) 2010-10-27

Family

ID=41434805

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0918912A Active GB2464825B (en) 2008-10-31 2009-10-29 Parenteral formulation for the combined delivery of iodised unsaturated vegetable oil and barium selenate

Country Status (3)

Country Link
GB (1) GB2464825B (en)
NZ (1) NZ572491A (en)
ZA (1) ZA200907464B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ538587A (en) * 2005-03-02 2007-07-27 Bomac Research Ltd Iodine and selenium deficiency prevention and treatment
NZ539006A (en) * 2005-03-22 2007-10-26 Agres Ltd Depot forming sustained release formulation for parenteral administration containing iodised oil and selenium
NZ547717A (en) * 2006-06-06 2008-05-30 Ultimate Equine Ltd An animal supplement and method of manufacture

Also Published As

Publication number Publication date
GB2464825B (en) 2010-10-27
IE20090833A1 (en) 2011-03-30
ZA200907464B (en) 2010-08-25
GB2464825A (en) 2010-05-05
NZ572491A (en) 2010-04-30

Similar Documents

Publication Publication Date Title
ZA201004793B (en) Capsule formulation
IL237392B (en) Pharmaceutical combination
HK1169960A1 (en) Pharmaceutical formulation
ZA201104348B (en) Pharmaceutical preparation
ZA201102446B (en) Oral formulation
GB0822633D0 (en) Formulation
GB0815972D0 (en) Pharmaceutical preparation
HU0800591D0 (en) Stable pharmaceutical combination
EP2268278A4 (en) Pharmaceutical composition
HK1152640A1 (en) Pharmaceutical combination
EP2306998A4 (en) Pharmaceutical formulation
GB0803054D0 (en) Medicament
IL208788A (en) Solid pharmaceutical formulation
IL212409A (en) Medicament dispenser
ZA201004772B (en) Novel formulation
GB0814376D0 (en) Formulation
HU0800414D0 (en) Pharmaceutical combination
GB0918912D0 (en) Improved medicament formulation
GB0805292D0 (en) Pharmaceutical formulation
GB0803395D0 (en) Medicament
GB0817663D0 (en) Formulation
GB0806445D0 (en) Formulation
GB0810217D0 (en) Pharmaceutical formulations
GB0813031D0 (en) Pharmaceutical formulations
HU0800741D0 (en) Improved pharmaceutical composition